当前位置: 首页 > 期刊 > 《中外女性健康研究》 > 20169
编号:13626731
胆囊癌的研究进展概述(3)
http://www.100md.com 2016年5月1日 《中外女性健康研究》 20169
     [18] Juan Carlos R,Quynh V,Juan Carlos A,et al.Inactivation of CDKN2A gene(p16)in gallbladder carcinoma[J].Revista Medica De Chile,2004,132(11):1369-1376.

    [19] Legan M,Luzar B,Ferlan-Marolt V,et al.Cyclooxygenase-2 expression determines neo-angiogenesis in gallbladder carcinomas[J].Bosnian journal of basic medical sciences/Udruenje basinih mediciniskih znanosti=Association of Basic Medical Sciences,2006,06(04):58-63.

    [20] Saetta A A.K-ras,p53 mutations,and microsatellite instability(MSI)in cancer[J].Journal of Surgical Oncology,2006,93(08):644-649.

    [21] Yu T,Ding R Y,Zhi Y H,et al.Analysis of p53 and vascular endothelial growth factor expression in human gallbladder carcinoma for the determination of tumor vascularity[J].World Journal of Gastroenterology,2006,12(03):415-419.

    [22] Koda M,Yashima K,Kawaguchi K,et al.Expression of Fhit,Mlh1,and P53 protein in human gallbladder carcinoma[J].Cancer Letters,2003,199(02):131-138.

    [23] Roa J C,Anabalón L,Roa I,et al.Promoter methylation profile in gallbladder cancer[J].Journal of Gastroenterology,2006,41(03):269-275., http://www.100md.com(徐志诚 赵长海 李准)
上一页1 2 3